Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 17Unknown 2Recruiting 2Active not recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 780Thoracic 18Genitourinary 17Breast 11Gynecologic 8Dermatologic 8Sarcoma 7Head & Neck 7Endocrine 5CNS 5Other solid neoplasm 4Lymphoid 4NET 3Plasma cell 2Other hematologic neoplasm 2Classical hematology 2Other neoplasm 1Other 1

Conditions

Leukemia, Myeloid, Acute 367Precursor Cell Lymphoblastic Leukemia-Lymphoma 288Leukemia 217Hematologic Neoplasms 156Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma 105Myelodysplastic Syndromes 90Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82Lymphoma, Non-Hodgkin 66Recurrence 62Lymphoma, Large B-Cell, Diffuse 51Lymphoma, Follicular 47Lymphoma, Mantle-Cell 45Multiple Myeloma 42Burkitt Lymphoma 41Leukemia, B-Cell 39Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 38Neoplasms 37Leukemia, Myeloid, Chronic-Phase 37Lymphoma, B-Cell 36Lymphoma, B-Cell, Marginal Zone 32Hodgkin Disease 29Lymphoma, Large-Cell, Immunoblastic 26Leukemia, Promyelocytic, Acute 22Leukemia, Myelomonocytic, Chronic 21Neoplasms, Plasma Cell 19Myeloproliferative Disorders 19Congenital Abnormalities 19Leukemia, Myelomonocytic, Acute 18Leukemia, Myeloid 18

Interventions

fludarabine 1Immunotherapy, Adoptive 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × Other hematologic neoplasm × Clear all
NCT03302403 2020-10-08

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

First Affiliated Hospital of Wenzhou Medical University

Phase NA Unknown
18 enrolled
GastrointestinalLymphoidOther hematologic neoplasmPlasma cell

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Leukemia, B-Cell, Lymphoma, B-Cell, Neoplasms, Plasma Cell

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Shenzhen BinDeBio Ltd.

Phase 1/2 Unknown
73 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡